{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidbv3rzpk47ll735n62ggj5z35bxv5radpe4u7vql6bjzugvv6bku",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mih6qbfshnb2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreidooyc2gpgp3zwaym24aua3bzhcwvn5bwlxh3zdzesqxlgq2n6qbq"
    },
    "mimeType": "image/jpeg",
    "size": 122517
  },
  "path": "/news/2026-04-common-metabolic-enzyme-cancer-immunotherapy.html",
  "publishedAt": "2026-04-01T12:40:03.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "Immunotherapies have transformed cancer treatment by helping the immune system recognize and attack tumors. They work for only about 20% of patients, though, and doctors still struggle to predict who will benefit.",
  "title": "Common metabolic enzyme could predict cancer immunotherapy benefits—and help more patients respond"
}